To identify a gene signature that could differentiate DCIS from ADH and IDC, we reanalyzed HTA data from our previous study [5] and observed the highest expression of CPB1 in DCIS than other lesions. This evidence concerns the gene CPB1 and ductal breast carcinoma in situ.